TB583R

N/A

Report date: 2025/11/20 16:04:15

NME

Base Information

Drug NameTB583R

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 bindersIntegrin beta-2 binders

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Integrin beta-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNorth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTwinpig Biolab Inc

China Registration ClassN/A

Develop Information

Active CompaniesTwinpig Biolab Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A